Cargando…

Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going

Indications for transcatheter aortic valve replacement (TAVR) have steadily increased over the last decade since the first trials including inoperable or very high risk patients. Thus, TAVR is now the most common treatment of aortic valve stenosis in elderly patients (vs. surgical aortic valve repla...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesnier, Jules, Panagides, Vassili, Nuche, Jorge, Rodés-Cabau, Josep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180932/
https://www.ncbi.nlm.nih.gov/pubmed/35683476
http://dx.doi.org/10.3390/jcm11113090
_version_ 1784723641511968768
author Mesnier, Jules
Panagides, Vassili
Nuche, Jorge
Rodés-Cabau, Josep
author_facet Mesnier, Jules
Panagides, Vassili
Nuche, Jorge
Rodés-Cabau, Josep
author_sort Mesnier, Jules
collection PubMed
description Indications for transcatheter aortic valve replacement (TAVR) have steadily increased over the last decade since the first trials including inoperable or very high risk patients. Thus, TAVR is now the most common treatment of aortic valve stenosis in elderly patients (vs. surgical aortic valve replacement -SAVR-). In this review, we summarize the current indications of TAVR and explore future directions in which TAVR indications can expand.
format Online
Article
Text
id pubmed-9180932
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91809322022-06-10 Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going Mesnier, Jules Panagides, Vassili Nuche, Jorge Rodés-Cabau, Josep J Clin Med Review Indications for transcatheter aortic valve replacement (TAVR) have steadily increased over the last decade since the first trials including inoperable or very high risk patients. Thus, TAVR is now the most common treatment of aortic valve stenosis in elderly patients (vs. surgical aortic valve replacement -SAVR-). In this review, we summarize the current indications of TAVR and explore future directions in which TAVR indications can expand. MDPI 2022-05-30 /pmc/articles/PMC9180932/ /pubmed/35683476 http://dx.doi.org/10.3390/jcm11113090 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mesnier, Jules
Panagides, Vassili
Nuche, Jorge
Rodés-Cabau, Josep
Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going
title Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going
title_full Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going
title_fullStr Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going
title_full_unstemmed Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going
title_short Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going
title_sort evolving indications of transcatheter aortic valve replacement—where are we now, and where are we going
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180932/
https://www.ncbi.nlm.nih.gov/pubmed/35683476
http://dx.doi.org/10.3390/jcm11113090
work_keys_str_mv AT mesnierjules evolvingindicationsoftranscatheteraorticvalvereplacementwherearewenowandwherearewegoing
AT panagidesvassili evolvingindicationsoftranscatheteraorticvalvereplacementwherearewenowandwherearewegoing
AT nuchejorge evolvingindicationsoftranscatheteraorticvalvereplacementwherearewenowandwherearewegoing
AT rodescabaujosep evolvingindicationsoftranscatheteraorticvalvereplacementwherearewenowandwherearewegoing